Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Opat

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
British Journal of Haematology|May 15, 2008
Oxidative haemolysis due to 'poppers'Jake Shortt, Mark N Polizzotto, Stephen S Opat, et al.
British Journal of Haematology|December 14, 2007
A drop of vitriol: microspherocytosis following sulphuric acid exposureM N Polizzotto, J Shortt, S S Opat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
The recognition of HLA-B27 by human CD4(+) T lymphocytesL H Boyle, J C Goodall, S S Opat, et al.
Lancet (London, England)|November 4, 1995
Clobazam for seizure prophylaxis during busulfan chemotherapyA P Schwarer, S S Opat, A L Watson, et al.
Infection Control and Hospital Epidemiology|October 20, 2020
Impact of coronavirus disease 2019 (COVID-19) pandemic isolation measures on the rate of non-COVID-19 infections in hematology patientsJemima H Miller, Stephen S Opat, Jake Shortt, et al.
Pathology|January 10, 1998
Disseminated echovirus infection after allogeneic bone marrow transplantationA P Schwarer, S S Opat, A M Watson, et al.
Bone Marrow Transplantation|July 21, 2009
Allo-SCT for hematological malignancies in the setting of HIVM N Polizzotto, M Skinner, M F Cole-Sinclair, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Annals of Hematology|March 3, 2009
Burkitt lymphoma in the setting of common variable immunodeficiencyMark N Polizzotto, Jeremy S McComish, Mark A Dawson, et al.
International Journal of Laboratory Hematology|November 20, 2008
A retrospective study of the utility of desmopressin (1-deamino-8-D-arginine vasopressin) trials in the management of patients with von Willebrand disorderJ Shortt, S S Opat, M B Gorniak, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
British Journal of Haematology|May 15, 2008
Oxidative haemolysis due to 'poppers'Jake Shortt, Mark N Polizzotto, Stephen S Opat, et al.
British Journal of Haematology|December 14, 2007
A drop of vitriol: microspherocytosis following sulphuric acid exposureM N Polizzotto, J Shortt, S S Opat, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
The recognition of HLA-B27 by human CD4(+) T lymphocytesL H Boyle, J C Goodall, S S Opat, et al.
Lancet (London, England)|November 4, 1995
Clobazam for seizure prophylaxis during busulfan chemotherapyA P Schwarer, S S Opat, A L Watson, et al.
Infection Control and Hospital Epidemiology|October 20, 2020
Impact of coronavirus disease 2019 (COVID-19) pandemic isolation measures on the rate of non-COVID-19 infections in hematology patientsJemima H Miller, Stephen S Opat, Jake Shortt, et al.
Pathology|January 10, 1998
Disseminated echovirus infection after allogeneic bone marrow transplantationA P Schwarer, S S Opat, A M Watson, et al.
Bone Marrow Transplantation|July 21, 2009
Allo-SCT for hematological malignancies in the setting of HIVM N Polizzotto, M Skinner, M F Cole-Sinclair, et al.
Blood Advances|October 9, 2021
Salvage radiotherapy is associated with durable response for a subset of patients with limited-stage refractory DLBCLJemima H Miller, Michael Gilbertson, Michael P MacManus, et al.
Annals of Hematology|March 3, 2009
Burkitt lymphoma in the setting of common variable immunodeficiencyMark N Polizzotto, Jeremy S McComish, Mark A Dawson, et al.
International Journal of Laboratory Hematology|November 20, 2008
A retrospective study of the utility of desmopressin (1-deamino-8-D-arginine vasopressin) trials in the management of patients with von Willebrand disorderJ Shortt, S S Opat, M B Gorniak, et al.
Pageof 4